Stock LUN LUNDBECK
Add to a list
To use this feature you must be a member
Log inSign up

Company Lundbeck Nasdaq Copenhagen

Equities

LUN

DK0061804697

Pharmaceuticals

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:58 2024-04-19 am EDT 		5-day change 1st Jan Change
27.9 DKK +0.36% Intraday chart for Lundbeck -3.29% -19.22%
Apr. 09 H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy MT
Apr. 09 Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD CI

Business Summary

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Number of employees: 5,681

Sales per Business

DKK in Million2022Weight2023Weight Delta
Rexulti/Rxulti
22.7 %
3,890 21.3 % 4,525 22.7 % +16.32%
Brintellix/Trintellix
21.7 %
4,277 23.4 % 4,324 21.7 % +1.10%
Other Pharmaceuticals
16.3 %
3,000 16.4 % 3,244 16.3 % +8.13%
Abilify Maintena
16.0 %
2,964 16.2 % 3,187 16.0 % +7.52%
Cipralex/Lexapro
10.7 %
2,360 12.9 % 2,135 10.7 % -9.53%
Vyepti
8.5 %
1,004 5.5 % 1,697 8.5 % +69.02%
Sabril
1.7 %
636 3.5 % 336 1.7 % -47.17%
Reconciling Items
1.6 %
277 1.5 % 327 1.6 % +18.05%
Exceptional Items
0.7 %
-588 -3.2 % 137 0.7 % -123.30%

Sales per region

DKK in Million2022Weight2023Weight Delta
United States
49.4 %
9,102 49.9 % 9,829 49.4 % +7.99%
International
25.1 %
5,203 28.5 % 4,991 25.1 % -4.07%
Europe
23.2 %
4,237 23.2 % 4,614 23.2 % +8.90%
Reconciling Items
1.6 %
277 1.5 % 327 1.6 % +18.05%
Exceptional Items
0.7 %
-588 -3.2 % 137 0.7 % -123.30%
Denmark
0.1 %
15 0.1 % 14 0.1 % -6.67%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 796,592,888 266,877,323 ( 33.50 %) 3,264,112 ( 0.4098 %) 30.74 %
Stock B 10 199,148,222 39,236,567 ( 19.70 %) 466,028 ( 0.2340 %)

Shareholders

NameEquities%Valuation
Lundbeck Foundation
66.00 %
525,751,306 66.00 % 2 534 M kr
Skagen AS (Investment Management)
0.5313 %
4,232,500 0.5313 % 20 M kr
Bankinter Gestión de Activos SA SGIIC
0.3720 %
2,963,575 0.3720 % 14 M kr
Evli Fund Management Co. Ltd.
0.2295 %
1,828,266 0.2295 % 9 M kr
Danske Bank A/S (Investment Management)
0.1713 %
1,364,170 0.1713 % 7 M kr
Sector Gamma AS
0.1648 %
1,312,784 0.1648 % 6 M kr
Canaccord Genuity Wealth Ltd.
0.1565 %
1,246,997 0.1565 % 6 M kr
Nykredit Bank A/S (Investment Management)
0.1258 %
1,002,230 0.1258 % 5 M kr
Union Bancaire Privée, UBP SA
0.0852 %
678,443 0.0852 % 3 M kr
State Street Global Advisors Ltd.
0.0718 %
572,304 0.0718 % 3 M kr
NameEquities%Valuation
Lundbeck Foundation
80.00 %
159,318,577 80.00 % 661 M kr
Nykredit Bank A/S (Investment Management)
0.4769 %
949,656 0.4769 % 4 M kr
Argenta Spaarbank NV
0.4555 %
907,125 0.4555 % 4 M kr
Danske Bank A/S (Investment Management)
0.1749 %
348,223 0.1749 % 1 M kr
Sparinvest SA (Denmark)
0.0968 %
192,805 0.0968 % 800 511 kr
UBS Asset Management (Deutschland) GmbH
0.0835 %
166,230 0.0835 % 690 174 kr
Eika Kapitalforvaltning AS
0.0773 %
153,866 0.0773 % 638 839 kr
Dimensional Fund Advisors Ltd.
0.0769 %
153,180 0.0769 % 635 991 kr
State Street Global Advisors Ltd.
0.0213 %
42,379 0.0213 % 175 954 kr
Sydbank A/S (Investment Management)
0.0121 %
24,021 0.0121 % 99 733 kr

Company contact information

H. Lundbeck A/S

Ottiliavej 9

2500, Valby

+45 36 30 13 11

http://www.lundbeck.com
address Lundbeck(LUN)

Group companies

NameCategory and Sector
Lundbeck Insurance A/S

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sales per region

Ratings for Lundbeck

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
32.7 DKK
Average target price
38.71 DKK
Spread / Average Target
+18.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
MCKESSON CORPORATION Stock McKesson Corporation
+13.36% 68.97B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+7.33% 26.32B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.34% 8.13B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-2.79% 7.92B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-24.02% 7.61B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+21.83% 4.49B
EBOS GROUP LIMITED Stock EBOS Group Limited
-2.28% 3.95B
GALENICA AG Stock Galenica AG
-3.51% 3.85B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+25.02% 3.73B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. HLUN B Stock
  4. LUN Stock
  5. Company Lundbeck